Rare diseases
Investigational molecules
Locations
239 conditions with trials, the busiest first
755 trials across Europe, recruiting first
A Phase III Study of Lenbelintide in Adults with Obesity or Overweight and Weight‑Related Comorbidity Without Type 2 Diabetes
BulgariaEffect of laroprovstat/rosuvastatin combination versus laroprovstat, rosuvastatin, and placebo on LDL‑C in hypercholesterolemia patients not previously treated with lipid‑lowering therapy
BulgariaEffect of lenbelintide (AZD6234) on body weight in adults with type 2 diabetes and obesity or overweight
GermanyPhase 3 Double‑Blind Study of Olatorepatide for Weight Loss in Adults with Overweight or Obesity Without Diabetes
GermanyEfficacy and Safety of Atumelnant, Hydrocortisone and Prednisone in Adults with ACTH‑Dependent Cushing’s Syndrome: A Phase 2/3 Dose‑Finding Study
AustriaEfficacy and Safety of Olatorepatide in Adults with Overweight or Obesity and Type 2 Diabetes
GermanyStudy of zenagamtide versus insulin glargine in adults with type 2 diabetes and high cardiovascular risk uncontrolled on oral medications
BulgariaEfficacy and Safety of Alogliptin Plus Empagliflozin Compared with Alogliptin Alone or Empagliflozin Alone in Adults with Type 2 Diabetes on Metformin
GermanyKAI-9531 in Adults With Obesity or Overweight and Diabetes
BulgariaStudy on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis
BulgariaStudy of Orforglipron in Overweight Adults at Risk of Developing Obesity‑Related Complications or Class 1 Obesity
CzechiaEfficacy and Safety of OXT-328 5% Topical Gel for Symptom Relief in Patients with Chemotherapy‑Induced, Diabetic, and Cervical Radiculopathy Peripheral Neuropathy
GreeceThe therapies tested most often in Metabolism and nutrition disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
